Shots:

• Siemens Healthineers to acquire Varian in an all-cash transaction- at a price of $177.50/ share with 42% to the 30-day volume-weighted average closing price of Varian's common stock as of July 31- 2020- making a total deal value ~$16.4B
• The transaction is expected to be closed in H1’21. The combined company will offer an integrated platform of end-to-end oncology solutions to addressing the complete continuum of cancer care- from screening and diagnosis to care delivery and post-treatment survivorship
• Varian and Siemens Healthineers will lead the digital transformation of oncology healthcare- enabling more efficient diagnosis- increased treatment quality and access- personalized precision cancer care- and improved outcomes for millions of patients worldwide

­ Ref: Varian | Image: Varian